127 related articles for article (PubMed ID: 518259)
1. Cellular and humoral response to Kunin antigen (CA) in ulcerative colitis and Crohn's disease.
Bartnik W; Kałuzewski S
Arch Immunol Ther Exp (Warsz); 1979; 27(4):531-8. PubMed ID: 518259
[TBL] [Abstract][Full Text] [Related]
2. Cellular immune reactions against common antigen, small intestine, and colon antigen in patients with Crohn's disease, ulcerative colitis, and cirrhosis of the liver.
Eckhardt R; Heinisch M; Meyer zum Büschenfelde KH
Scand J Gastroenterol; 1976; 11(1):49-54. PubMed ID: 1251132
[TBL] [Abstract][Full Text] [Related]
3. [Lipid A antibody titers and O antibody titers in Crohn's disease, ulcerative colitis and acute enteritis (author's transl)].
Schüssler P; Kruis W; Marget W
Med Klin; 1976 Oct; 71(44):1898-902. PubMed ID: 825710
[TBL] [Abstract][Full Text] [Related]
4. Anti-Saccharomyces cerevisiae mannan antibodies in inflammatory bowel disease: comparison of different assays and correlation with clinical features.
Annese V; Piepoli A; Perri F; Lombardi G; Latiano A; Napolitano G; Corritore G; Vandewalle P; Poulain D; Colombel JF; Andriulli A
Aliment Pharmacol Ther; 2004 Nov; 20(10):1143-52. PubMed ID: 15569117
[TBL] [Abstract][Full Text] [Related]
5. Circulating antibodies and leucocyte migration inhibition to colon-associated antigen in ulcerative colitis and Crohn's disease.
Marcussen H; Bendixen G
Scand J Gastroenterol; 1974; 9(2):149-52. PubMed ID: 4206480
[No Abstract] [Full Text] [Related]
6. [Serodiagnosis of Crohn's disease].
Auer IO; Wensinck F; Röder A; Merwe JP; Schmidt H; Schuster S
Dtsch Med Wochenschr; 1983 Aug; 108(33):1242-6. PubMed ID: 6872878
[TBL] [Abstract][Full Text] [Related]
7. Antigen specificity of circulating anti-neutrophil cytoplasmic antibodies in inflammatory bowel disease.
Kossa K; Coulthart A; Ives CT; Pusey CD; Hodgson HJ
Eur J Gastroenterol Hepatol; 1995 Aug; 7(8):783-9. PubMed ID: 7496870
[TBL] [Abstract][Full Text] [Related]
8. Immunoresponsiveness in ulcerative colitis and Crohn's disease--effect of colectomy and suppression of disease activity.
Lyanga J; Davis P; Thomson AB
West J Med; 1988 Apr; 148(4):421-5. PubMed ID: 3388844
[TBL] [Abstract][Full Text] [Related]
9. Alterations in serum anti-alpha-galactosyl antibodies in patients with Crohn's disease and ulcerative colitis.
D'Alessandro M; Mariani P; Lomanto D; Bachetoni A; Speranza V
Clin Immunol; 2002 Apr; 103(1):63-8. PubMed ID: 11987986
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibody 1F10 immunoreactivity in inflammatory bowel disease: a new marker specific only for continuous endothelial cells.
Lügering N; Stoll R; Holzgreve A; Winde G; Sorg C; Domschke W
Eur J Gastroenterol Hepatol; 1995 Aug; 7(8):777-81. PubMed ID: 7496869
[TBL] [Abstract][Full Text] [Related]
11. [Antibody titer to Bacteroides fragilis is increased in Crohn disease patients with fistula development].
Pietsch M; Brake BA; Schulz TF; Dierich MP
Z Gastroenterol; 1986 May; 24(5):269-75. PubMed ID: 2425502
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of leucocyte migration by antigens from human colon and E. coli O 14 in patients with ulcerative colitis.
Fixa B; Komárová O; Skaunic V; Nerad M; Kojecký Z; Benỳŝek L
Scand J Gastroenterol; 1975; 10(5):491-3. PubMed ID: 1098133
[TBL] [Abstract][Full Text] [Related]
13. Differential levels of granzyme B, regulatory cytokines, and apoptosis in Crohn's disease and ulcerative colitis at first presentation.
Jenkins D; Seth R; Kummer JA; Scott BB; Hawkey CJ; Robins RA
J Pathol; 2000 Feb; 190(2):184-9. PubMed ID: 10657017
[TBL] [Abstract][Full Text] [Related]
14. A study of peripheral leucocyte migration in agarose medium in inflammatory bowel disease.
Bartnik W; Swarbrick ET; Williams C
Gut; 1974 Apr; 15(4):294-300. PubMed ID: 4834555
[TBL] [Abstract][Full Text] [Related]
15. Direct hospital costs for patients with inflammatory bowel disease in a Canadian tertiary care university hospital.
Bernstein CN; Papineau N; Zajaczkowski J; Rawsthorne P; Okrusko G; Blanchard JF
Am J Gastroenterol; 2000 Mar; 95(3):677-83. PubMed ID: 10710056
[TBL] [Abstract][Full Text] [Related]
16. CD40 and CD86 upregulation with divergent CMRF44 expression on blood dendritic cells in inflammatory bowel diseases.
Vuckovic S; Florin TH; Khalil D; Zhang MF; Patel K; Hamilton I; Hart DN
Am J Gastroenterol; 2001 Oct; 96(10):2946-56. PubMed ID: 11693331
[TBL] [Abstract][Full Text] [Related]
17. [Immunologic studies in patients with Crohn disease and ulcerative colitis].
Sauer H; Sauer D; Bendix U; Schumann B
Allerg Immunol (Leipz); 1984; 30(1):23-33. PubMed ID: 6203390
[TBL] [Abstract][Full Text] [Related]
18. Leukocyte migration inhibitory factor (LMIF) release by human colonic lymphocytes.
Bartnik W; ReMine SG; Shorter RG
Arch Immunol Ther Exp (Warsz); 1981; 29(3):397-405. PubMed ID: 6271090
[TBL] [Abstract][Full Text] [Related]
19. In vitro cellular cytotoxicity in Crohn's disease and ulcerative colitis: relation with disease activity and treatment, and the effect of recombinant gamma-interferon.
Aparició-Pagés MN; Verspaget HW; Peña AS; Weterman IT; de Bruin PA; Mieremet-Ooms MA; van der Zon JM; van Tol EA; Lamers CB
J Clin Lab Immunol; 1989 Jul; 29(3):119-24. PubMed ID: 2517428
[TBL] [Abstract][Full Text] [Related]
20. Antibodies against laminaribioside and chitobioside are novel serologic markers in Crohn's disease.
Dotan I; Fishman S; Dgani Y; Schwartz M; Karban A; Lerner A; Weishauss O; Spector L; Shtevi A; Altstock RT; Dotan N; Halpern Z
Gastroenterology; 2006 Aug; 131(2):366-78. PubMed ID: 16890590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
